Delayed Australian S.E. 11:32:57 2023-02-27 pm EST 5-day change 1st Jan Change
0.001 AUD -.--% Intraday chart for ANALYTICA -.--% -.--%
Sales 2021 801K 523K Sales 2022 285K 186K Capitalization 4.61M 3.01M
Net income 2021 -1M -652K Net income 2022 -2M -1.3M EV / Sales 2021 9.15 x
Net cash position 2021 1.89M 1.23M Net Debt 2022 420K 274K EV / Sales 2022 17.6 x
P/E ratio 2021
-4.74 x
P/E ratio 2022
-2 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 41.65%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0.001
0.01
5 years
0.00
Extreme 0.001
0.01
10 years
0.00
Extreme 0.001
0.05
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 08-10-06
Chief Operating Officer - 07-12-31
Director/Board Member - -
Members of the board TitleAgeSince
Director/Board Member 76 17-05-22
Chairman - 04-06-27
Director of Finance/CFO - 08-10-06
More insiders
Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.
More about the company